Physician profile
Patrick L Wupperman
NPI 1538276001
$1,104.81
in general payments reported to CMS, 2019-2025
14 companies · $74.83 in 2025
The $74.83 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $143 · 2021: $161 · 2022: $241 · 2023: $157 · 2024: $140 · 2025: $74.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $169.59 | 2023-2025 | Durolane, Durolane, Xcell |
| Stryker Corporation | $162.04 | 2021-2023 | Inspace |
| Pacira Therapeutics, INC. | $157.22 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $149.31 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $131.50 | 2019-2023 | Euflexxa |
| Biorez, INC. | $115.27 | 2022 | |
| Depuy Synthes Sales INC. | $54.94 | 2019-2025 | Orthovisc, Monovisc |
| Pylant Medical | $42.58 | 2024 | |
| Avanos Medical | $33.60 | 2024 | On-Q* Pump and Accessories |
| Kci USA, INC. | $27.54 | 2023 | Prevena |
| Vericel Corporation | $23.48 | 2021 | |
| Axogen | $20.35 | 2020 | |
| Solventum Corporation | $15.40 | 2024 | V.A.C. Veraflo |
| Orthofix Medical, INC. | $1.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Wupperman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.